Medical researcher Fayzan Rab combines clinical expertise with tech industry experience to investigate the economic and public health implications of psychedelic therapy implementation. His research at Emory's Center for Psychedelics and Spirituality focuses on crucial questions about accessibility, minority inclusion, and healthcare system integration.

Distinguished McGill University Professor Emeritus Dr. Michael Meaney shares groundbreaking insights into how environmental factors influence genetic expression and brain development. His research bridges molecular biology and public health, revolutionizing our understanding of early-life experiences' impact on long-term health outcomes.

Hebrew University's Professor Raz Yirmiya shares pioneering discoveries about inflammation's role in depression. His research at the Laboratory for Psychoneuroimmunology has transformed our understanding of depression's biological foundations, opening new pathways for innovative treatments targeting immune system responses.